News, stories and opinions for the business innovators of the world.

Evident Corporation and Planet Innovation enter into long-term strategic partnership

Roger LangsdonMarketing Director

Planet Innovation (“PI”), a healthtech contract design and manufacturing company, and Evident Corporation (“Evident”), a wholly owned subsidiary of Olympus Corporation constituting its former Scientific Solutions business and a global leader in microscopy and imaging solutions, today announced a long-term strategic partnership to develop and manufacture innovative digital workflow solutions for life science markets.

The new partnership agreement further strengthens the relationship which has been built over a number of years through the successful R&D collaboration for the design of new, breakthrough instruments.

PI CEO, Stuart Elliott, said, “Evident and PI share a common purpose of making people’s lives healthier, safer and more fulfilling.  By leveraging PI’s combination of design innovation and manufacturing capabilities we believe we are a perfect partner to support Evident on this quest.”

Evident Head of Life Science Strategy, Motoki Inoue, commented, “Evident’s goal is to provide products and services that support our customers as they advance the standard of life science around the world. Our collaboration with PI will support us as we continue to expand our range of advanced solutions.”

Roger Langsdon Marketing Director
Roger Langsdon

Roger is the Marketing Director at Planet Innovation and a specialist marketing and communications professional with a focus on growing an organization’s reputation and revenue through strategic marketing and high-impact communications.

Roger Langsdon

Sign up for the Perspectives newsletter:

A roundup of the latest news and opinions from PI.

Related Articles.

Photo of expert panel with Kurt Pickle, Krystal Santiago and Prahalad Arasu.

Perspectives from expert panel: Future-proofing your manufacturing strategy for regulated medtech devices


Hear from an expert panel on how medtech companies can make good, strategic decisions that future-proof them against changing regulatory and market conditions.

Dermapen range in PI's manufacturing facility

50,000th Dermapen rolls off PI’s production line


Planet Innovation and Dermapenworld are celebrating more than 50,000 Dermapen micro-needling instruments produced at PI’s manufacturing facility and shipped for distribution to more than 80 countries worldwide.

Cell and Gene Therapy Expert Roundtable

Perspectives from expert roundtable: Strategies to attract funding for C&GT manufacturing tools

Product Development

Planet Innovation held an exclusive roundtable at Advanced Therapies Week on ‘Strategies to Attract Funding for C&GT Manufacturing Tools’. Here are the highlights

Dollar signs in cells

Effective strategies for securing investor funding in cell and gene manufacturing tools development

Product Development

We share insights from investors on what they prioritize when evaluating funding opportunities for cell and gene therapy tools.